IMRX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own IMRX shares is 65, representing 30.11% of the company's common stock.

ORACLE ALPHA INC., in the last quarter, reduced its stake in IMRX by -5.33% restricting it's holding to 11.17 thousand shares of worth nearly $32.27K. AMERICAN INTERNATIONAL GROUP, INC. also lessened -0.84% of the IMRX shares from its portfolio, reducing its holding to 11.03 thousand shares of worth $31.89K. GOLDMAN SACHS GROUP INC also shunned IMRX shares holding by -0.62% last quarter which brought its holding to 454.23 thousand shares worth $1.31M.

As per its latest 13F filing, NEW YORK STATE COMMON RETIREMENT FUND increased its stake in IMRX by 6.31% in the last quarter. The institutional holder raised its holding to 9.67 thousand shares having worth more than $28.00K. VANGUARD GROUP INC also added 12.09% more shares of IMRX to its portfolio, raising its holding to 1.2 million shares of worth $3.48M. GEODE CAPITAL MANAGEMENT, LLC also increased its IMRX shares holding by 4.12% which brought its holding to 462.52 thousand shares worth $1.34M.

The insider with the most stakes in IMRX is Cormorant Asset Management, LP , 10 percent owner at the company. Additionally, IMRX stock is highly held by PRESIDENT AND CEO Zeskind Benjamin J. and director CARPENTER ROBERT J among others.

Company executives, directors, and other insiders own 29.12% percent of Immuneering Corporation's stock. Within the last six months, there have been 0 transaction(s) in which IMRX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include CORMORANT ASSET MANAGEMENT, LP.

There have been 0 transaction(s) during the past 6-months in which Immuneering Corporation insiders have bought stock, totalling 0 shares

Around 0 Immuneering Corporation shares are held by insiders, which represents about 29.12% of IMRX stock.

IMRX 10 percent owner, Cormorant Asset Management, LP holds the largest portfolio of the company's shares. IMRX shares owned by Cormorant total nearly 2.9 million.

NEW YORK STATE COMMON RETIREMENT FUND is the largest institutional owner in IMRX which holds 9.67 thousand shares worth $28.00K or 0.03% of the total IMRX shares outstanding followed by ORACLE ALPHA INC. with ownership of 11.17 thousand shares representing 0.04% of the IMRX ownership. AMERICAN INTERNATIONAL GROUP, INC. is the third largest stakeholder with 11.03 thousand shares or 0.04% of the ownership worth more than $31.89K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the IMRX is concerned, it is a stock which is not optionable.

Number of IMRX shares short is 2.05M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 31.05M shares of IMRX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, IMRX has 19.11M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for IMRX is 1.19.